Showing results (81-90 of 149) with videos related to
Sort By:
Pageof 15
Journal of Virology|January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cellsHeidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.Journal of Hepatology|February 24, 2009
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variabilityLukas Weseslindtner, Christoph Neumann-Haefelin, Sergei Viazov, et al.Plos Pathogens|December 5, 2012
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitopeJulia Schmidt, Astrid K N Iversen, Stefan Tenzer, et al.Journal of Gastroenterology and Hepatology|October 3, 2014
PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survivalKilian Friedrich, Andreas Wannhoff, Stefan Kattner, et al.JCI Insight|November 10, 2025
Limited vaccine-induced CD8+ T cell immunity in HIV-infected immunological nonrespondersVivien Karl, Anne Graeser, Anastasia Kremser, et al.European Radiology|March 28, 2019
How to report incidental findings from population whole-body MRI: view of participants of the German National CohortPeter Hegedüs, Oyunbileg von Stackelberg, Christoph Neumann, et al.Journal of Medical Virology|December 24, 2009
Hepatitis C virus recombinants are rare even among intravenous drug usersSergei Viazov, Stefan S Ross, Karen K Kyuregyan, et al.Journal of Hepatology|April 24, 2022
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitisTobias Boettler, Benedikt Csernalabics, Henrike Salié, et al.Journal of the American College of Cardiology|June 29, 2019
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSonia S Anand, John W Eikelboom, Leanne Dyal, et al.Pageof 15